Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?

Background: Upfront cytoreductive nephrectomy (CN) is no longer the standard of care for patients with metastastic renal cell carcinoma (mRCC) with intermediate or poor prognosis according to the International mRCC Database Consortium categories. Objective: To investigate indications for CN followin...

Полное описание

Библиографические подробности

Главные авторы:	Elisabeth E. Fransen van de Putte, Luna van den Brink, Mohamed A. Mansour, Johannes C. van der Mijn, Sofie Wilgenhof, Johannes V. van Thienen, John B.A.G. Haanen, Ekaterini Boleti, Thomas Powles, Patricia J. Zondervan, Niels M. Graafland, Axel Bex
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2023-09-01
Серии:	European Urology Open Science
Предметы:	Cytoreductive Ipilimumab Nephrectomy Nivolumab Indications
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2666168323003798
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!